- CHG cloths more effective in reducing risk for acquiring HAIs
- Study shows 64 percent decreased risk of infection from MRSA or VRE
- May be beneficial for both ICU and general medical unit patients
PROVIDENCE, R.I. - A new study from Rhode Island Hospital has found a reduced risk of hospital-acquired infections (HAI) when using two percent chlorhexidine gluconate (CHG) cloths for daily bathing instead of soap and water. The study found a 64 percent decrease in the risk of acquiring an infection from either methicillin-resistant Staphylococcus aureus (MRSA) or Vancomycin-resistant Enterococcus (VRE). The study is published online in advance of print in the journal Infection Control and Hospital Epidemiology.
CHG is an antiseptic that has been shown to reduce the risk of hospital infections in patients in intensive care units but it had not previously been studied in other patient populations. Senior investigator Leonard Mermel, D.O., Sc.M., medical director of the department of epidemiology and infection control at Rhode Island Hospital, and his colleagues conducted a study on general medical hospital units to determine if daily bathing of patients using CHG cloths would be effective in reducing the risk of MRSA and VRE HAIs, as opposed to daily soap and water bathing.
Mermel, who is also a professor of medicine at The Warren Alpert Medical School of Brown University, says, "The results of our study indicate a significant reduction in the risk of developing an HAI due to MRSA or VRE. We believe that this study demonstrates that daily CHG bathing may be a beneficial infection control intervention for patients outside of the ICU setting."
In the study, a group of 7,699 adult patients admitted to general medicine units were bathed daily with CHG cloths for the duration of their admission. The control group was a group of 7,102 patients who were bathed with soap and water. Through the study, bathing was performed by certified nursing assistants. The two percent CHG cloths were kept in dedicated warmers and used according to the manufacturer's guidelines.
Steven Kassakian, M.D., is a resident who worked with Mermel and colleagues on the study. He says, "Obviously our results require further investigation but I think this study represents a fundamental step forward in patient safety and it certainly feels good to be involved in that. As a resident physician, being involved in this study was a tremendous opportunity and it feels very satisfying to think this work may have some remarkable and immediate benefits for our patients."
Mermel adds, "Our results require confirmation before CHG bathing in non-ICU patients becomes a standard of care. Nonetheless, our findings have certain strengths, including our large sample size."
Kassakian also adds, "While the findings of this study are preliminary, I think it's very exciting that the results are so substantial and novel that changing an essentially rudimentary and basic task, such as bathing can have such a profound effect on patient outcomes."
The researchers call for further studies on this easily adopted method of providing care to patients in non-ICU settings in order to continue to reduce HAIs in hospitals throughout the country.
Mermel is also a physician with University Medicine, (www.umfmed.org), a non-profit, multi-specialty medical group practice employing many of the full-time faculty of the department of medicine of the Alpert Medical School.
Other researchers involved in the study with Mermel and Kassakian include Julie Jefferson, R.N., M.P.H.; Stephen Parenteau, M.S.; and Jason T. Machan, Ph.D., all of Rhode Island Hospital and Alpert Medical School.
About Rhode Island Hospital
Founded in 1863, Rhode Island Hospital (www.rhodeislandhospital.org) in Providence, RI, is a private, not-for-profit hospital and is the principal teaching hospital of The Warren Alpert Medical School of Brown University. A major trauma center for southeastern New England, the hospital is dedicated to being on the cutting edge of medicine and research. Rhode Island Hospital receives nearly $50 million each year in external research funding. It is a founding member of the Lifespan health system.